UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example MedicinalProductDefinition: Xylocain-WOP-2-Gel-SE-AJ-MPD

Generated Narrative: MedicinalProductDefinition Xylocain-WOP-2-Gel-SE-AJ-MPD

identifier: http://ema.europa.eu/fhir/mpId/SE-100001718-00010445, http://ema.europa.eu/fhir/eurdId/10933

domain: Human use

status: Current

combinedPharmaceuticalDoseForm: Gel

indication:

Ytanestesi av uretra vid kateterisering, sondering samt andra endouretrala ingrepp. Ytanestesi vid ano-, rekto- och sigmoidoskopi samt vid rektal palpation. Smärtsamma cystiter. Xylocain gel är avsett för vuxna och barn i alla åldrar.

legalStatusOfSupply: Medicinal product subject to medical prescription

classification: lidocaine

name

productName: Xylocain utan konserveringsmedel 2% Gel

part

part: Xylocain

type: Invented Name Part

part

part: utan konserveringsmedel

type: Formulation Name Part

part

part: 2%

type: Strength part

part

part: Gel

type: Pharmaceutical dose form part

Usages

-CountryLanguage
*Kingdom of SwedenSwedish